Characterization of the selectivity and mechanism of human cytochrome P450 inhibition by the human immunodeficiency virus-protease inhibitor nelfinavir mesylate. [electronic resource]
- Drug metabolism and disposition: the biological fate of chemicals Jul 1998
- 609-16 p. digital
Publication Type: Journal Article
0090-9556
Adolescent Adult Anti-HIV Agents--pharmacology Cytochrome P-450 CYP3A Cytochrome P-450 Enzyme Inhibitors HIV Protease Inhibitors--pharmacology Humans Isoenzymes--antagonists & inhibitors Male Microsomes, Liver--enzymology Mixed Function Oxygenases--antagonists & inhibitors Nelfinavir--metabolism